The outcome of reflux oesophagitis: does drug-induced remission mean cure?
Savarino
V
V
Chair of Gastroenterology, University of Genova, Italy.
Celle
G
G
D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D004942:Esophagitis, Peptic / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D004947:Esophagus / Q000187:drug effects; D005753:Gastric Mucosa / Q000187:drug effects / Q000473:pathology; D005764:Gastroesophageal Reflux / Q000150:complications; D006635:Histamine H2 Antagonists / Q000008:administration & dosage*; D006801:Humans; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists